SRPT Sarepta Therapeutics · $17.22 Lagging — relative weakness落后 — 相对弱势 Terminal终端 ↗

All coverage所有股票 · Health Care

Sarepta Therapeutics · Health Care

SRPT

$17.22
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States.SareptaTherapeutics,Inc.是一家医疗研究与药物开发公司，其公司办公室和研究设施位于美国马萨诸塞州剑桥市。
Speculative / unprofitable投机／未盈利 Small cap小盘 $2B
Engine stance引擎立场2026-07-20
Lagging — relative weakness落后 — 相对弱势
The bottoming setup is not yet confirmed (price still below the 10-day average) and the 3-day/weekly momentum is rolling筑底形态尚未确认（价格仍位于 10 日均线下方），且3 日/周线动量已开始掉头向下——动量在形态完成前已开始衰竭。等待价格收复 10 日均线且动量趋于稳定后再考虑建仓。
Open in Terminal打开终端 ↗ All coverage所有股票 Data through数据截至 2026-07-20 · regenerated nightly每日更新

Key Statistics关键统计

Price价格
$17.22
29.6% below 52-week high低于52周高点 29.6%
Market Cap市值
$2B
Normal volume正常成交量
Beta贝塔
2.12
Moves about 2.1x the market波动幅度约为市场的 2.1 倍
RSI (14)RSI（14）
44
Neutral zone中性区域
Next Earnings下次财报
2026-08-05 (17d)
Volatility Rank波动率分位
28th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
27.4% of float

Performance价格表现

Period周期 SRPT S&P 500vs Index对比指数
1 Week近1周 -9.1% -1.5% Lagged the index by 7.6 points落后指数 7.6 个百分点
1 Month近1月 +1.5% +0.6% In line with the index与指数基本持平
3 Months近3月 -20.1% +4.7% Lagged the index by 24.8 points落后指数 24.8 个百分点
6 Months近6月 -18.5% +7.8% Lagged the index by 26.3 points落后指数 26.3 个百分点
Year to date年初至今 -19.2% +9.1% Lagged the index by 28.3 points落后指数 28.3 个百分点
1 Year近1年 -21.6% +19.4% Lagged the index by 41.0 points落后指数 41.0 个百分点
3 Years近3年 -83.8% +69.4% Lagged the index by 153.2 points落后指数 153.2 个百分点

Technicals技术面

RSI (14)RSI（14） 44 Neutral zone中性区域
vs 50-day相对50日均线 -2.2% vs 50-day avg
vs 200-day相对200日均线 -12.7% vs 200-day avg
Volatility rank波动率分位 28th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$16.52
Don't chase above不追高于
$17.22
Stop止损
$15.00
Extended — wait for a pullback过度拉伸 — 等待回撤

Earnings财务业绩

17
days until next report天后公布财报
2026-08-05

Estimates being cut预期下调

Earnings call transcripts — coming soon财报电话会议记录 — 即将上线

Valuation估值

Multiple指标 SRPT Sector median行业中位 Cheaper than相对便宜
P/B市净率 1.58x 3.52
87%
P/S市销率 0.82x 3.02
86%
Earnings yield盈利收益率 -39.47% 2.72
3%
FCF yield自由现金流收益率 -17.01% 3.94
1%
Shareholder yield股东收益率 1.38% 1.89
37%
Analyst price targets — coming soon分析师目标价 — 即将上线

Financials财务数据

Revenue营业收入
$540.1M
2020
$701.9M
2021
$933.0M
2022
$1.2B
2023
$1.9B
2024
$2.2B
2025
5yr CAGR5年复合增速: 32.4%
Earnings Per Share每股收益
$-7.11
2020
$-5.15
2021
$-8.03
2022
$-5.80
2023
$2.34
2024
$-7.13
2025
Free Cash Flow自由现金流
$25.3M
2020
-$481.7M
2021
-$356.2M
2022
-$577.1M
2023
-$342.7M
2024
-$307.5M
2025
Margins利润率
Operating margin营业利润率
-31.8%
Net margin净利率
-32.5%
FCF margin自由现金流利润率
-9.3%
-62.5%Return on Equity股本回报率
-21.3%Return on Assets资产回报率
Leverage杠杆
Current ratio流动比率2.32
Capital Allocation资本配置
Stock-based comp股权薪酬$123.4M
Share count change (1y)股数变化（1年）+8.3%
Piotroski皮奥特罗斯基 3/8 Altman Z阿尔特曼Z: distress (-1.1) Warning警示

Snapshot Gauges综合指标

Valuation vs Sector估值相对行业
Looks cheap vs sector相对行业偏便宜
Cheaper than 58% of its sector on blended multiples综合估值倍数低于行业内 58% 的公司
Beta市场敏感度
2.12×
0.21×3×
Moves about 2.1× the market波动幅度约为市场的 2.1 倍
Financial Health财务健康
3/8
Altman阿尔特曼: distress
Weak financial health财务健康状况偏弱
Dividend分红
—
Does not pay a dividend不派发股息

Why Is It Moving为何波动

Macro宏观 Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓 Short interest changed +14.2%空头仓位变动 +14.2%
Technical技术面 SRPT daily MACD crossed downSRPT 日线MACD下穿

Ownership & Smart Money持仓与聪明钱

Insider activity内部人员活动: -$0.4M net (0 buyers, 2 sellers)-$0.4M 净值（0 买家，2 卖家）
Concentrated ownership集中持仓
Fund基金 Grade评级 Activity动作 % of portfolio组合占比 As of截至
RA Capital Management D New position新建仓 0.9% 2026-03-31

Signal History信号历史

NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP. Buyers rejected the 2026-06-11 low (swing low printed) but price hasn't reclaimed its 10-day average — first box ticked, not all. Last cycle was left-translated (topped early) — a bearish structural tell买入预备。买方拒绝了 2026-06-11 的低点（摆动低点已现），但价格尚未收复 10 日均线——第一项条件达成，并非全部。 上一周期为左移结构（见顶偏早）——属于看空的结构性信号
TURN SIGNALED BOTTOMING
Jul 16, 2026
SRPT daily MACD crossed downSRPT 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $17.23.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$17.23。
Jul 10, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 10, 2026
SRPT lost its 200-day averageSRPT 跌破200日均线
Price closed below the 200-day moving average — the classic bear dividing line. $18.95.收盘跌破200日均线 — 经典的空头分界线。$18.95。
Jul 7, 2026
SRPT reclaimed its 200-day averageSRPT 收复200日均线
Price closed back above the 200-day moving average — the classic bull dividing line. $19.79.收盘重回200日均线 — 经典的多头分界线。$19.79。
Jul 6, 2026
UPTREND → BOTTOMING上涨趋势 → 筑底中
BUY SETUP买入预备
Jul 1, 2026
BOTTOMING → UPTREND筑底中 → 上涨趋势
HOLD持有
Jun 26, 2026
UNCONFIRMED TURN → BOTTOMING未确认转向 → 筑底中
BUY SETUP买入预备
Jun 25, 2026
NEARING A HIGH → UNCONFIRMED TURN接近高点 → 未确认转向
HIGH-RISK · NIMBLE ONLY高风险 · 仅限灵活操作

Showing last 15 of显示最近15条，共 242 signals条信号

Factor Profile因子特征

Composite factor score综合因子得分: -0.68
Value价值
-1.9
Quality质量
+0.7
Investment资本投入
+1.4
Shareholder payout股东回报
-0.7
Low volatility低波动
-3.0
Low market beta低市场敏感度
-1.8
Earnings quality盈利质量
+1.6
Short interest空头兴趣
-2.7

Company Profile公司档案

Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States.SareptaTherapeutics,Inc.是一家医疗研究与药物开发公司，其公司办公室和研究设施位于美国马萨诸塞州剑桥市。
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。
Open Analyzer打开分析器 Browse All Stocks浏览所有股票